Status:
UNKNOWN
Clinical Application of 18F-PFPN PET Imaging in Diagnosis and Staging of Clear Cell Sarcoma of Soft Tissue
Lead Sponsor:
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Conditions:
Clear Cell Sarcoma of Soft Tissue
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is a prospective monocentric study aimed to evaluate the diagnosis and staging value of 18F-PFPN PET in clear cell sarcoma of soft tissue. Patients with clinically suspected or confirmed cl...
Detailed Description
Clear cell sarcoma of soft tissue is a rare malignancy derived from neural crest cells that contain melanin and/or melanin precursors. Melanin is an important target for the diagnosis of clear cell sa...
Eligibility Criteria
Inclusion
- Adult patients (age 18 years or above), regardless of gender;
- Patients with clinically suspected or confirmed clear cell sarcoma of soft tissue (supporting evidence including visual examination, MRI, CT, ultrasound, and histopathological examination, etc.) ;
- Patients who agree to undergo both 18F-PFPN and 18F-FDG PET imaging.
Exclusion
- Acute systemic diseases and electrolyte disturbances;
- Patients who plan to get pregnant within six months or are pregnant or breastfeeding;
- The patient or his/her legal representative is unable or unwilling to sign the informed consent.
Key Trial Info
Start Date :
June 21 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05963035
Start Date
June 21 2023
End Date
June 30 2024
Last Update
July 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China, Hubei Province
Wuhan, Hubei, China, 430022